Helius Medical announces corporate name change to Solana Company

Helius Medical Technologies announced that, following receipt of approval from its Board of Directors, it has filed an amendment to its Certificate of Incorporation with the Delaware Secretary of State and amended the Second Amended and Restated Bylaws to reflect a corporate name change from “Helius Medical Technologies, Inc.” to “Solana Company (HSDT).” The company’s ticker symbol for its Class A common stock, HSDT, will remain the same. Additionally, the company and certain of its investors entered into a non-binding letter of intent with the Solana Foundation, which sets forth the principal terms of HSDT’s commitment to abide by “Solana By Design” terms, which includes conducting all on-chain activity solely on Solana, institutional partnerships referrals, and joint initiatives to highlight Solana capabilities. HSDT will have the option, subject to certain conditions, to purchase a certain amount of SOL tokens from the Foundation at a discount. The company is also continuing to execute on its accumulation of SOL tokens as part of its digital asset treasury strategy. The company still holds cash from its recent $500M PIPE financing, which the company intends to use to further its digital asset treasury strategy.